Walaa E. Kattan

475 total citations
12 papers, 295 citations indexed

About

Walaa E. Kattan is a scholar working on Molecular Biology, Cell Biology and Nephrology. According to data from OpenAlex, Walaa E. Kattan has authored 12 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Cell Biology and 3 papers in Nephrology. Recurrent topics in Walaa E. Kattan's work include Cellular transport and secretion (5 papers), Parathyroid Disorders and Treatments (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Walaa E. Kattan is often cited by papers focused on Cellular transport and secretion (5 papers), Parathyroid Disorders and Treatments (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Walaa E. Kattan collaborates with scholars based in United States, Saudi Arabia and Türkiye. Walaa E. Kattan's co-authors include John F. Hancock, Ransome van der Hoeven, Roua A. Al‐Rijjal, Brian F. Meyer, Yufei Shi, Minjing Zou, Yong Zhou, Dina Montufar‐Solis, Junchen Liu and Essa Y. Baitei and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Walaa E. Kattan

12 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Walaa E. Kattan United States	10	185	62	50	44	40	12	295
Stefania Cotta Doné United States	6	190 1.0×	51 0.8×	28 0.6×	64 1.5×	29 0.7×	7	324
Anna Perfetti Italy	9	294 1.6×	51 0.8×	24 0.5×	23 0.5×	28 0.7×	9	399
Phyllis S. Frisa United States	11	260 1.4×	39 0.6×	18 0.4×	23 0.5×	27 0.7×	13	397
Shinya Kikuchi Japan	11	365 2.0×	55 0.9×	21 0.4×	41 0.9×	16 0.4×	19	523
JM Tavaré United Kingdom	8	416 2.2×	61 1.0×	58 1.2×	49 1.1×	35 0.9×	11	571
Douglas Quinn United States	6	315 1.7×	26 0.4×	56 1.1×	16 0.4×	24 0.6×	7	522
Sunao Asaumi Japan	10	218 1.2×	33 0.5×	20 0.4×	21 0.5×	30 0.8×	11	342
Dorothée Ruffieux-Daidié Switzerland	8	316 1.7×	33 0.5×	116 2.3×	17 0.4×	33 0.8×	8	370
Andrea Toell Germany	8	116 0.6×	45 0.7×	63 1.3×	77 1.8×	142 3.5×	10	345
Shaikh Abu Hossain United States	8	240 1.3×	111 1.8×	162 3.2×	24 0.5×	51 1.3×	8	424

Countries citing papers authored by Walaa E. Kattan

Since Specialization

Citations

This map shows the geographic impact of Walaa E. Kattan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walaa E. Kattan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walaa E. Kattan more than expected).

Fields of papers citing papers by Walaa E. Kattan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walaa E. Kattan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walaa E. Kattan. The network helps show where Walaa E. Kattan may publish in the future.

Co-authorship network of co-authors of Walaa E. Kattan

This figure shows the co-authorship network connecting the top 25 collaborators of Walaa E. Kattan. A scholar is included among the top collaborators of Walaa E. Kattan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walaa E. Kattan. Walaa E. Kattan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Liu, Junchen, Ransome van der Hoeven, Walaa E. Kattan, et al.. (2023). Glycolysis regulates KRAS plasma membrane localization and function through defined glycosphingolipids. Nature Communications. 14(1). 465–465. 32 indexed citations

Kattan, Walaa E., et al.. (2021). Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity. Nature Communications. 12(1). 5248–5248. 27 indexed citations

Kattan, Walaa E., Junchen Liu, Dina Montufar‐Solis, et al.. (2021). Components of the phosphatidylserine endoplasmic reticulum to plasma membrane transport mechanism as targets for KRAS inhibition in pancreatic cancer. Proceedings of the National Academy of Sciences. 118(51). 32 indexed citations

Kattan, Walaa E., et al.. (2020). Abstract 1085: Interrogating the RAS interactome identifies EFR3A as a novel enhancer of RAS oncogenesis. Cancer Research. 80(16_Supplement). 1085–1085. 1 indexed citations

Kattan, Walaa E. & John F. Hancock. (2020). RAS Function in cancer cells: translating membrane biology and biochemistry into new therapeutics. Biochemical Journal. 477(15). 2893–2919. 22 indexed citations

Cho, Kwang‐Jin, et al.. (2019). Acylpeptide hydrolase is a novel regulator of KRAS plasma membrane localization and function. Journal of Cell Science. 132(15). 17 indexed citations

Kattan, Walaa E., Wei Chen, Xiaoping Ma, et al.. (2019). Targeting plasma membrane phosphatidylserine content to inhibit oncogenic KRAS function. Life Science Alliance. 2(5). e201900431–e201900431. 30 indexed citations

Acar, Sezer, Korcan Demir, Roua A. Al‐Rijjal, et al.. (2018). Clinical and genetic characteristics of 15 families with hereditary hypophosphatemia: Novel Mutations in PHEX and SLC34A3. PLoS ONE. 13(3). e0193388–e0193388. 22 indexed citations

Zou, Minjing, Ali S. Alzahrani, Ali Al‐Odaib, et al.. (2018). Molecular Analysis of Congenital Hypothyroidism in Saudi Arabia: SLC26A7 Mutation Is a Novel Defect in Thyroid Dyshormonogenesis. The Journal of Clinical Endocrinology & Metabolism. 103(5). 1889–1898. 50 indexed citations

10.

Güven, Ayla, Roua A. Al‐Rijjal, Minjing Zou, et al.. (2017). Mutational analysis of PHEX, FGF23 and CLCN5 in patients with hypophosphataemic rickets. Clinical Endocrinology. 87(1). 103–112. 22 indexed citations

11.

Demir, Korcan, Walaa E. Kattan, Minjing Zou, et al.. (2015). Novel CYP27B1 Gene Mutations in Patients with Vitamin D-Dependent Rickets Type 1A. PLoS ONE. 10(7). e0131376–e0131376. 33 indexed citations

12.

Zou, Minjing, Roua A. Al‐Rijjal, Nesibe Andıran, et al.. (2014). Hypophosphatemic rickets caused by a novel splice donor site mutation and activation of two cryptic splice donor sites in the PHEX gene. Journal of Pediatric Endocrinology and Metabolism. 28(1-2). 211–6. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact